(NASDAQ: NTRA) Natera's forecast annual revenue growth rate of 13.6% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.44%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.71%.
Natera's revenue in 2025 is $2,116,674,000.On average, 24 Wall Street analysts forecast NTRA's revenue for 2025 to be $310,946,589,645, with the lowest NTRA revenue forecast at $283,757,740,040, and the highest NTRA revenue forecast at $325,576,122,935. On average, 24 Wall Street analysts forecast NTRA's revenue for 2026 to be $362,287,970,625, with the lowest NTRA revenue forecast at $328,060,383,305, and the highest NTRA revenue forecast at $388,510,718,975.
In 2027, NTRA is forecast to generate $431,433,217,590 in revenue, with the lowest revenue forecast at $390,580,935,950 and the highest revenue forecast at $486,086,945,730.